Efferent Labs Taps Evotec to Advance Implantable Biosensor for R&D, Oncology
Efferent Labs has inked a deal with Evotec to develop its implantable biosensor technology.
January 18, 2017
NEWS AND EVENTS
Amazing blog post
News
Efferent Labs Signs Agreement With Evotec AG To Continue Development Of Groundbreaking Medical Diagnostic Product
Efferent Labs Signs Agreement With Evotec AG To Continue Development Of Groundbreaking Medical Diagnostic Product
January 9, 2017
Could a Biosensor Help Personalize Cancer Treatment?
Innovate WNY – Could a Biosensor Help Personalize Cancer Treatment?
September 16, 2016
Life-Sciences Accelerator Program Selects Efferent Labs
Efferent Labs chosen to participate in Life-science accelerator program.
September 16, 2016
Efferent Labs to Present at 2016 NewYorkBIO Annual Conference
FOR MORE INFORMATION CONTACT: press@efferentlabs.com
April 16, 2016
October 30, 2014
Events
Efferent Labs to Present at Bright Buffalo Niagara Event
FOR MORE INFORMATION CONTACT: press@efferentlabs.com
Efferent Labs presents the novel CytoComm™ Living Biosensor at Health Care Capital Forum
March 19, 2013
Contact: Mike Barra (mbarra@ralandcorp.com)
Direct Phone: 585-598-1180 ext. 740
Our transformative technology platform will dramatically reduce R&D costs.